European Journal of Surgical Oncology
Volume 35, Issue 3 , Pages 258-263, March 2009

Locoregional recurrence in breast carcinoma patients

  • E. Yıldırım

      Affiliations

    • Corresponding Author InformationKonutkent-2, A-4 Blok 44, Cayyolu 06530, Ankara, Turkey. Tel.: +90 312 240 2951; fax: +90 312 345 4979.

Department of Surgery, Ankara Oncology Training and Research Hospital, Ankara, Turkey

Accepted 9 June 2008.

Abstract 

Aims

To assess the risk of locoregional recurrence (LRR) after mastectomy and to identify predictive and treatment factors that affect the risk of LRR.

Methods

The primary endpoint was local recurrence. Univariate and multivariate Cox regression analyses were carried out in the data from 1217 patients.

Results

The median follow-up was 74months, and 63 (5.2%) patients experienced a LRR in their follow-up period. In the multivariate analysis, age group (≤35years vs. >35years, p<0.0001; Hazard Ratio [HR], 5.0; 95% Confidence Interval [95% CI], 3.0–8.3), tumour size (>2cm vs. ≤2cm, p=0.03; HR, 2.2; 95% CI, 1.2–4.7) and LVI (yes vs. no, p<0.0001; HR, 3.2; 95% CI,1.9–5.2) were the independent prognostic factors for LRR. This analysis, in the final model, indicated that adjuvant radiotherapy and adjuvant tamoxifen were associated with a reduced risk of LRR by 90% and 75%, respectively, across the follow-up period, whereas age group remained as an important risk factor (p=0.002; HR, 3.0; 95% CI, 1.5–6.2).

Conclusions

Although adjuvant therapies reduce the risk of LRR, young age is an independent risk factor for LRR.

Keywords: Breast carcinoma, Mastectomy, Prognosis, Local recurrence, Radiotherapy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0748-7983(08)00206-0

doi:10.1016/j.ejso.2008.06.010

European Journal of Surgical Oncology
Volume 35, Issue 3 , Pages 258-263, March 2009